PURIFICATION OF MELANOMA 250 KD TUMOR-ASSOCIATED ANTIGEN

Award Information

Agency: Department of Health and Human Services	Branch: N/A	Award ID: 7162	Program Year/Program: 1987 / SBIR
Agency Tracking Number: 7162	Solicitation Year: N/A	Solicitation Topic Code: N/A	Solicitation Number: N/A

Small Business Information: Piedmont Research Company
3508 University Dr Suite #2 Durham, NC 27707
View profile »

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No

Phase 1: Fiscal Year: 1987

Title: PURIFICATION OF MELANOMA 250 KD TUMOR-ASSOCIATED ANTIGEN

Agency: HHS

Contract: N/A

Award Amount: $50,000.00

Abstract:
THE GOAL OF THIS PROJECT IS TO IMPROVE THE EXISTING PURIFICATION PROCEDURE, DEVELOPED BY PIEDMONT RESEARCH COMPANY, FOR THE 250 KD MELANOMA TUMOR-ASSOCIATED ANTIGEN (TAA) TO ALLOW PRODUCTION OF ADEQUATE QUANTITIES OF PURIFIEDTAA FOR CLINICAL EVALUATION. PURIFIED TAA MAY PROVE AN EFFICIENT AGENT FOR IMMUNOTHERAPY AND FOR SPECIFIC IN VITRO ACTIVATION OF PATIENT T CELLS FOR SUBSEQUENT THERAPY. BOTH THE PURIFICATION PROCEDURE AND THE TAA PRODUCT WILL HAVE COMMERCIAL APPLICATIONS. BASIC METHODOLOGICAL APPROACHES WILL INCLUDE EVALUATION OF ALTERNATIVE TAA SOLUBILIZATION PROCEDURES, USE OF IMMUNOADHERENCE CHROMATOGRAPHY, AND EVALUATION OF THE DESTRUCTIVE EFFECTS OFENDOGENOUS PROTEASE ACTIVITY.

Principal Investigator:
Gary m stuhlmiller phd
9199680433

Business Contact:

Small Business Information at Submission:

Piedmont Research Company
3508 University Dr Suite #2 Durham, NC 27707

EIN/Tax ID:

DUNS: N/A

Number of Employees: N/A

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No